Rhinosporidiosis
Rhinosporidiosis is a chronic infective disorder caused by Rhinosporidium seeberi. It is characterized by polypoidal lesions that primarily affect the mucous membranes of the nose and nasopharynx. Other sites of the body can also be involved, including the eyes, ears, and skin. The disease is endemic in India and Sri Lanka, but cases have been reported worldwide.
Etiology
The causative agent of rhinosporidiosis is Rhinosporidium seeberi, a unique organism that has been difficult to classify. It was initially thought to be a fungus, but recent molecular studies suggest that it is a protistan parasite related to the fish parasites in the class Mesomycetozoea.
Clinical Features
The disease presents as painless, polypoidal, friable masses that are pink to red in color. The lesions are often pedunculated and have a characteristic "strawberry-like" appearance due to the presence of numerous white dots on the surface, which represent the sporangia of the organism. The most common site of involvement is the nasal mucosa, followed by the nasopharynx, oropharynx, and conjunctiva. Other sites such as the skin, bones, and genitalia can also be involved, but this is rare.
Diagnosis
The diagnosis of rhinosporidiosis is made by clinical examination and confirmed by histopathological examination of the excised lesion. The characteristic finding is the presence of numerous mature and immature sporangia in the subepithelial tissue.
Treatment
The mainstay of treatment is surgical excision of the lesion. Recurrence is common, and regular follow-up is necessary. Medical treatment with dapsone has been tried with variable success.
Epidemiology
Rhinosporidiosis is endemic in India and Sri Lanka, but cases have been reported from many parts of the world. The disease affects both humans and animals, and transmission is thought to occur through contact with spores in water or dust.
References
<references />
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


